Goldman Sachs initiates coverage of medtech stocks Insulet and Dexcom at Buy
Go back to Goldman Sachs initiates coverage of medtech stocks Insulet and Dexcom at Buy| DexCom, Inc. (NASDAQ: DXCM) | Delayed: 89.71 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $89.71 | 52 Week High | $96.38 | |||
| Open | $89.71 | 52 Week Low | $47.92 | |||
| Day High | $89.71 | P/E | N/A | |||
| Day Low | $89.71 | EPS | $-0.42 | |||
| Volume | 136 | |||||
| Insulet Corporation (NASDAQ: PODD) | Delayed: 150.58 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $150.58 | 52 Week High | $45.60 | |||
| Open | $150.58 | 52 Week Low | $23.94 | |||
| Day High | $150.58 | P/E | N/A | |||
| Day Low | $150.58 | EPS | $-1.00 | |||
| Volume | 37 | |||||
